<VariationArchive VariationID="440483" VariationName="NM_205850.3(SLC24A5):c.641del (p.Leu214fs)" VariationType="Deletion" Accession="VCV000440483" Version="42" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-04-15" DateCreated="2017-10-01" MostRecentSubmission="2024-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="434110" VariationID="440483">
      <GeneList>
        <Gene Symbol="SLC24A5" FullName="solute carrier family 24 member 5" GeneID="283652" HGNC_ID="HGNC:20611" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48120990" stop="48142672" display_start="48120990" display_stop="48142672" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48413168" stop="48434588" display_start="48413168" display_stop="48434588" Strand="+" />
          </Location>
          <OMIM>609802</OMIM>
        </Gene>
        <Gene Symbol="MYEF2" FullName="myelin expression factor 2" GeneID="50804" HGNC_ID="HGNC:17940" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48134632" stop="48178295" display_start="48134632" display_stop="48178295" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48431628" stop="48470557" display_start="48431628" display_stop="48470557" Strand="-" />
          </Location>
          <OMIM>619395</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_205850.3(SLC24A5):c.641del (p.Leu214fs)</Name>
      <CanonicalSPDI>NC_000015.10:48136732:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48136733" stop="48136733" display_start="48136733" display_stop="48136733" variantLength="1" positionVCF="48136732" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48428930" stop="48428930" display_start="48428930" display_stop="48428930" variantLength="1" positionVCF="48428929" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>L214fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.48136733del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.48136733del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.48428930del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.48428930del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011500.1" sequenceAccession="NG_011500" sequenceVersion="1" change="g.20762del">
            <Expression>NG_011500.1:g.20762del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_205850.3" sequenceAccession="NM_205850" sequenceVersion="3" change="c.641del" MANESelect="true">
            <Expression>NM_205850.3:c.641del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_995322.1" sequenceAccession="NP_995322" sequenceVersion="1" change="p.Leu214fs">
            <Expression>NP_995322.1:p.Leu214fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001301210.2" sequenceAccession="NM_001301210" sequenceVersion="2" change="c.*6175del">
            <Expression>NM_001301210.2:c.*6175del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016132.5" sequenceAccession="NM_016132" sequenceVersion="5" change="c.*6175del" MANESelect="true">
            <Expression>NM_016132.5:c.*6175del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA7545932" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="609802.0005" DB="OMIM" />
        <XRef Type="rs" ID="772398324" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00003" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00003" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00003" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_205850.3(SLC24A5):c.641del (p.Leu214fs) AND Oculocutaneous albinism type 6" Accession="RCV000508792" Version="38">
        <ClassifiedConditionList TraitSetID="11507">
          <ClassifiedCondition DB="MedGen" ID="C3805375">Oculocutaneous albinism type 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-09-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_205850.3(SLC24A5):c.641del (p.Leu214fs) AND not provided" Accession="RCV002524930" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-10-01" MostRecentSubmission="2024-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23985994</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26686029</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-21">
          <Description>Affects</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-12-17">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-10-27">
          <Description>Affects</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-10-26">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-10-04">
          <Description>Affects</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-10-01">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-03-27">
          <Description>Affects</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-12-10">
          <Description>Affects</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-12-09">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="11507" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="18203" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Albinism, oculocutaneous, type VI</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Oculocutaneous albinism type 6</ElementValue>
                <XRef ID="MONDO:0018264" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OCA6</ElementValue>
                <XRef Type="MIM" ID="113750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17599" />
                <XRef ID="17599" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">37053367</ID>
                <ID Source="BookShelf">NBK590568</ID>
              </Citation>
              <XRef ID="370097" DB="Orphanet" />
              <XRef ID="C3805375" DB="MedGen" />
              <XRef ID="MONDO:0018264" DB="MONDO" />
              <XRef Type="MIM" ID="113750" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1172467" SubmissionDate="2017-09-27" DateLastUpdated="2024-04-15" DateCreated="2017-10-01">
        <ClinVarSubmissionID localKey="609802.0005_ALBINISM, OCULOCUTANEOUS, TYPE VI" title="SLC24A5, 1-BP DEL, 641T_ALBINISM, OCULOCUTANEOUS, TYPE VI" />
        <ClinVarAccession Accession="SCV000605917" DateUpdated="2024-04-15" DateCreated="2017-10-01" Type="SCV" Version="34" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-21">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 Portuguese brothers and their cousin with oculocutaneous albinism (OCA6; 113750), Morice-Picard et al. (2014) identified homozygosity for a 1-bp deletion (c.641delT) in exon 6 of the SLC24A5 gene, resulting in a frameshift and premature termination (Leu214ArgfsTer12). The mutation segregated with the disorder and was not found in the HapMap or 1000 Genomes Project databases. No mutations in 7 other OCA-associated genes had been identified in this family.</Attribute>
              <Citation>
                <ID Source="PubMed">23985994</ID>
              </Citation>
              <XRef DB="OMIM" ID="113750" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC24A5" />
          </GeneList>
          <Name>SLC24A5, 1-BP DEL, 641T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 641T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609802.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALBINISM, OCULOCUTANEOUS, TYPE VI</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6131351" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4922259|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003442907" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23985994</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26686029</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23985994</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu214Argfs*12) in the SLC24A5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC24A5 are known to be pathogenic (PMID: 23985994, 26686029). This variant is present in population databases (rs772398324, gnomAD 0.009%). This premature translational stop signal has been observed in individual(s) with clinical features of oculocutaneous albinism (PMID: 23985994). ClinVar contains an entry for this variant (Variation ID: 440483). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC24A5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.48428930del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6131351" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1172467" TraitType="Disease" MappingType="Name" MappingValue="ALBINISM, OCULOCUTANEOUS, TYPE VI" MappingRef="Preferred">
        <MedGen CUI="C3805375" Name="Oculocutaneous albinism type 6" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001520104</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

